Voyager Therapeutics Inc (MEX:VYGR)
MXN 165 0 (0%) Market Cap: 7.30 Bil Enterprise Value: 776.10 Mil PE Ratio: 30.23 PB Ratio: 1.08 GF Score: 71/100

Q2 2023 Voyager Therapeutics Inc Earnings Call Transcript

Aug 03, 2023 / 12:30PM GMT
Release Date Price: MXN155.5
Operator

Good morning, and welcome to the Voyager Therapeutics Second Quarter 2023 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. A replay of today's call will be available on the Investors section of the company website approximately 2 hours after completion of this call.

I would now like to turn the call over to Pete Pfreundschuh, Chief Financial Officer. Please go ahead.

Peter P. Pfreundschuh
Voyager Therapeutics, Inc. - CFO

Thank you, and good morning. Joining me on the call today are Dr. Al Sandrock, our Chief Executive Officer; Dr. Todd Carter, our Chief Scientific Officer. We issued our Q2 2023 financial results press release this morning. The press release and the 10-Q are available on our website.

In a moment, I will turn the call over to Al. Before I do this, I want to remind everyone that during this call, Voyager representatives may make forward-looking statements as noted in Slide 2 of today's deck. These forward-looking statements include future expectations, plans

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot